Search | ARVO Journals

Showing 1 – 20 of 1175

SORT:

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Fractal analysis in birdshot chorioretinopathy using optical coherence tomography angiography

Edmund Tsui; Sivan Elyashiv; C Michael Samson; Sarwar Zahid; Richard B Rosen; Joshua A Young

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2158. doi:

Biochemistry and Molecular Biology November 2018

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy

PDF

Joost Brinks; Elon H. C. van Dijk; Mahmoud Habeeb; Aikaterini Nikolaou; Roula Tsonaka; Hendrika A. B. Peters; Hetty C. M. Sips; Arjanneke F. van de Merbel; Eiko K. de Jong; Robbert G. E. Notenboom; Szymon M. Kielbasa; Silvère M. van der Maarel; Paul H. A. Quax; Onno C. Meijer; Camiel J. F. Boon
TAGS: hydrocortisone, endothelial cells, adrenal corticosteroids, glucocorticoids, patient isolation, mineralocorticoids, agonists, antagonists, central serous chorioretinopathy, chronic exertional compartment syndrome
Invest. Ophthalmol. Vis. Sci.. 2018; 59(13):5682-5692. doi: 10.1167/iovs.18-25054

Includes: Supplemental Content

Genetics November 2018

Genome-Wide Association Study to Identify a New Susceptibility Locus for Central Serous Chorioretinopathy in the Japanese Population

PDF

Akiko Miki; Yoichi Sakurada; Koji Tanaka; Kentaro Semba; Yoshinori Mitamura; Mitsuko Yuzawa; Atsushi Tajima; Masahiro Nakatochi; Ken Yamamoto; Keitaro Matsuo; Issei Imoto; Shigeru Honda
TAGS: disease susceptibility, single nucleotide polymorphism, central serous chorioretinopathy, genome-wide association study, japanese
Invest. Ophthalmol. Vis. Sci.. 2018; 59(13):5542-5547. doi: 10.1167/iovs.18-25497

Includes: Supplemental Content

Retina September 2018

Retinal Vascular Reactivity in Central Serous Chorioretinopathy

PDF

Felice Cardillo Piccolino; Marco Lupidi; Carlo Cagini; Daniela Fruttini; Massimo Nicolò; Chiara Maria Eandi; Silvia Tito

Invest. Ophthalmol. Vis. Sci.. 2018; 59(11):4425-4433. doi: 10.1167/iovs.18-24475

Retina August 2018

Choroidal Vascular Reactivity in Central Serous Chorioretinopathy

PDF

Felice Cardillo Piccolino; Marco Lupidi; Carlo Cagini; Daniela Fruttini; Massimo Nicolò; Chiara Maria Eandi; Silvia Tito
TAGS: angiogram, hypertension, hemodynamics, vascular flow, diagnostic imaging, stress, central serous chorioretinopathy, study population, doppler hemodynamics, chief complaint
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):3897-3905. doi: 10.1167/iovs.18-23995

ARVO Annual Meeting Abstract July 2018

Characterization of central serous chorioretinopathy associated with subretinal fibrin.

Agustina C Palacio; Sebastian Inchauspe; emilio dodds

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4250. doi:

ARVO Annual Meeting Abstract July 2018

Focal Laser Therapy in Symptomatic Central Serous Chorioretinopathy

Musa Abdelaziz; Michael M Lai

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3124. doi:

ARVO Annual Meeting Abstract July 2018

Natural course, intravitreal bevacizumab injection responsiveness and OCT angiography (OCTA) findings of central serous chorioretinopathy patients; flat pigment epithelium detachment (PED) Vs focal PED

Dong Yoon Kim; Ju Byung Chae; Young Min Park; Jisoo Kim; Jin Young Kim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3125. doi:

ARVO Annual Meeting Abstract July 2018

A Novel Contrast Sensitivity Test as a New Measure of Visual Function in Central Serous Chorioretinopathy

Anna Marmalidou; Esther Lee Kim; Rebecca Silverman; Merina Thomas; Ines Lains; Alice Choi; Ava K Bittner; Leo A Kim; Luis A Lesmes; David N. Zacks; John B Miller

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3126. doi:

ARVO Annual Meeting Abstract July 2018

Reduction of sub-retinal fluid associated with central serous chorioretinopathy after the use of topical non-steroidal anti-inflammatory medications

Kyle MacLean; Sepehr Bahadorani; Nathan Gresores; Kendall Wannamaker; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3127. doi:

ARVO Annual Meeting Abstract July 2018

Salivary alpha amylase activity is increased in active central serous chorioretinopathy

Lebriz Altay; Paula Scholz; Vasilena Sitnilska; Elon H. Van Dijk; Alberto M. Pereira; Femke M. van Haalen; Isha Akhtar; Camiel Boon; Sascha Fauser

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3128. doi:

ARVO Annual Meeting Abstract July 2018

Patients with Central Serous Chorioretinopathy have increased hair cortisol concentrations

Janine Lenk; Dirk Sandner; Lutz E Pillunat; Egbert Matthe

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3129. doi:

ARVO Annual Meeting Abstract July 2018

Phenotypic risk factors for treatment outcome in patients with chronic central serous chorioretinopathy

Vasilena Sitnilska; Robert Hoerster; Sascha Fauser; Lebriz Altay

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3131. doi:

ARVO Annual Meeting Abstract July 2018

Untargeted large spot half-fluence photodynamic therapy for chronic central serous chorioretinopathy

Aseel Hamoud Hamoud Bedan; Goncalo Almeida

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3132. doi:

ARVO Annual Meeting Abstract July 2018

Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization

Chieko Shiragami; Yukari Takasago; Rie Osaka; Mamoru Kobayashi; Aoi Ono; Ayana Yamashita; Kazuyuki Hirooka

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3133. doi:

ARVO Annual Meeting Abstract July 2018

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Thomas Jurian van Rijssen; Elon H. Van Dijk; Greet Dijkman; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3134. doi:

ARVO Annual Meeting Abstract July 2018

Changes in choroidal thickness after focal laser photocoagulation in the patients with acute central serous chorioretinopathy

Kyu Young Shim; Kwang-Soo Kim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3135. doi:

ARVO Annual Meeting Abstract July 2018

Sleep Apnea Increased The Risk of Central Serous Chorioretinopathy

Pei-Kang Liu; Ming-Ju Tsai; Jen-Yu Hung; Kwou-Yeung Wu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5536. doi:

ARVO Annual Meeting Abstract July 2018

Risk of recurrent and chronic disease in a large cohort of acute central serous chorioretinopathy with long-term follow-up

Danial Mohabati; Tom O A R Missotten; Eiko de Jong; Camiel Boon; Suzanne Yzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6075. doi:

ARVO Annual Meeting Abstract July 2018

3-year results of short-duration multiple-session subthreshold micropulse yellow laser (577-nm) for chronic central serous chorioretinopathy

Han Sang Park; Si Yeol Kim; Oh Woong Kwon; Yang Jae Kim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6193. doi:

1 2 3 4 5

Next 20 Results »

Search Results for Chorioretinopathy

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Fractal analysis in birdshot chorioretinopathy using optical coherence tomography angiography

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy

Genome-Wide Association Study to Identify a New Susceptibility Locus for Central Serous Chorioretinopathy in the Japanese Population

Retinal Vascular Reactivity in Central Serous Chorioretinopathy

Choroidal Vascular Reactivity in Central Serous Chorioretinopathy

Characterization of central serous chorioretinopathy associated with subretinal fibrin.

Focal Laser Therapy in Symptomatic Central Serous Chorioretinopathy

Natural course, intravitreal bevacizumab injection responsiveness and OCT angiography (OCTA) findings of central serous chorioretinopathy patients; flat pigment epithelium detachment (PED) Vs focal PED

A Novel Contrast Sensitivity Test as a New Measure of Visual Function in Central Serous Chorioretinopathy

Reduction of sub-retinal fluid associated with central serous chorioretinopathy after the use of topical non-steroidal anti-inflammatory medications

Salivary alpha amylase activity is increased in active central serous chorioretinopathy

Patients with Central Serous Chorioretinopathy have increased hair cortisol concentrations

Phenotypic risk factors for treatment outcome in patients with chronic central serous chorioretinopathy

Untargeted large spot half-fluence photodynamic therapy for chronic central serous chorioretinopathy

Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Changes in choroidal thickness after focal laser photocoagulation in the patients with acute central serous chorioretinopathy

Sleep Apnea Increased The Risk of Central Serous Chorioretinopathy

Risk of recurrent and chronic disease in a large cohort of acute central serous chorioretinopathy with long-term follow-up

3-year results of short-duration multiple-session subthreshold micropulse yellow laser (577-nm) for chronic central serous chorioretinopathy

Search Results for Chorioretinopathy

To View More...

You must be signed into an individual account to use this feature.